Partners HealthCare
VC Fund
Boston, United States
Partners HealthCare is a VC fund in Boston focused on Health Care and Biotechnology. Partners HealthCare was founded in 1994 by Brigham and Women's Hospital and Massachusetts General Hospital. Partners is an integrated health care system that offers patients a continuum of coordinated high-quality care. The system includes primary care and specialty physicians, community hospitals, the two founding academic medical centers,specialty facilities, community health centers, and other health-related entities. Partners HealthCare is a non-profit organization.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Partners HealthCare invests in
Stages Partners HealthCare invests in
Countries Partners HealthCare invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Eugene Braunwald
|
|||
Gary L. Gottlieb
|
|||
|
Brent L. Henry
|
|||
David Torchiana
|
|||
|
Gregg Meyer
|
|||
| See all 12 contacts → | |||
Investment Focus
Industry
- Health Care 4 (57%)
- Biotechnology 3 (43%)
- Software 2 (29%)
- RFID 1 (14%)
- Beauty 1 (14%)
Stage
- Series A 3 (43%)
- Series B 2 (29%)
- Series D 1 (14%)
- Funding Round 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Eugene Braunwald
VP
|
VP | Total investments: 0 | Find email | |
|
Gary L. Gottlieb
Senior Management
|
Senior Management | Total investments: 0 | Find email | |
|
Brent L. Henry
Vice President and General Counsel
|
Vice President and General Counsel | Total investments: 0 | Find email | |
|
David Torchiana
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
|
Gregg Meyer
Chief Clinical Officer
|
Chief Clinical Officer | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lyndra Therapeutics
|
Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing them with its oral, ultra-long-acting, sustained-release therapies. Administering and conveniently distributing medicines in weekly or longer-term doses – including using polypill approaches – will improve safety, efficacy, and adherence to maximizeglobal health impact and lower overall healthcare costs. | $60.9M / Series B / Feb 11, 2019 | |
|
Lyndra Therapeutics
|
Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing them with its oral, ultra-long-acting, sustained-release therapies. Administering and conveniently distributing medicines in weekly or longer-term doses – including using polypill approaches – will improve safety, efficacy, and adherence to maximizeglobal health impact and lower overall healthcare costs. | $23M / Series A / Apr 13, 2017 | |
Health Catalyst
|
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical. | $70M / Series D / Mar 17, 2015 | |
T2 Biosystems
|
T2 Biosystems is a private company developing a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single, easy-to-use instrument. The company's proprietary technology combines nanotechnology and miniaturized magnetic resonance (MR) technology and eliminates the need for costly andtime-consuming sample preparation. | $10.8M / Series B / Oct 17, 2008 | |
Provasculon
|
Provasculon was founded to exploit the discovery by Richard Lee, MD, a cardiologist at Brigham and Women's Hospital and Associate Professor at Harvard Medical School, and Vincent Segers, MD, a researcher at Brigham and Women's Hospital, of novel forms of the growth factor Stromal Cell-Derived Factor-1 (SDF-1). | $6M / Series A / Mar 24, 2008 | |
Freedom2
|
Tattoos are all about self-expression and personal style; they're a way to showcase your unique point of view. And how many times have you changed your mind? Remember Angelina's ode to Billy Bob? We all know their love didn't last as long as the art commemorating it.Freedom2 was founded nearly ten years ago with the crazy ideathat a permanent tattoo might be removable. Typical tattoo ink is made from insoluble pigments and remains in the skin forever. Laser treatments can be costly and painful, and ultimately might not even remove the tattoo completely. Thinking that there's got to be a better alternative, our founders began pursuing the idea that there could be a way to make tattoos that were permanent, and less expensive to remove. And thus the idea of the Particle Encapsulation and Enhancement (P2E) Platform was born. | $1.5M / Series A / Mar 28, 2007 | |
Radianse
|
Radianse provides intelligent solutions for businesses with their real-time tracking services. Their advanced software automatically collects and processes a variety of live data on any asset. The situation history is recorded and easily accessible through their Radianse Awareness Suite from any web-enabled device.Their mission is to improvethe way businesses operate by providing accessible, affordable, andcustomized solutions that automatically integrate data sources into real-time actionable intelligence.They aim to be the market leader in the providing of situation awareness coupled with actionable intelligence. Their goal is to deliver innovative, technology-based applications that allow their customers to manage their resources, control costs, increase revenue opportunities, and improve overall operational efficiency.Radianse has achieved significant milestones in developing cutting-edge algorithms and methodologies to deliver reliable products with superior accuracy and performance. All of their products are covered by one or more patents with additional U.S. and international patents pending.Radianse is committed to constantly innovating and evolving. They began as an engineering organization focused on Radio Frequency Identification (RFID) technology-based solutions. Their aim was to automatically and continuously monitor high-value hospital assets. Radianse now works with many clients from various industries. Radianse remains focused on being committed to innovative research and development.Radianse is applying its leadership and extensive networking knowledge along with inventive technology designs to launch new and advanced applications. They are committed to innovation and delivering intelligent solutions for any industry. | $2M / Dec 03, 2004 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Partners HealthCare invest in?
Partners HealthCare invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Partners HealthCare?
Public channels for Partners HealthCare include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Partners HealthCare?
The team at Partners HealthCare includes Eugene Braunwald (VP), Gary L. Gottlieb (Senior Management) and Brent L. Henry (Vice President and General Counsel), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
